Products & Services · Total revenues
Net product revenues — Total revenues
Alnylam Pharmaceuticals Net product revenues — Total revenues increased by 4.2% to $1.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 121.1%, from $468.54M to $1.04B. Over 4 years (FY 2021 to FY 2025), Net product revenues — Total revenues shows an upward trend with a 45.7% CAGR.
Analysis
Metric ID:
alny_segment_net_product_revenues_total_revenuesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $160.81M | $167.04M | $198.51M | $186.87M | $213.52M | $232.27M | $261.68M | $276.33M | $305.71M | $313.15M | $346.29M | $365.16M | $410.09M | $420.15M | $450.83M | $468.54M | $672.21M | $851.08M | $994.72M | $1.04B |
| QoQ Change | — | +3.9% | +18.8% | -5.9% | +14.3% | +8.8% | +12.7% | +5.6% | +10.6% | +2.4% | +10.6% | +5.5% | +12.3% | +2.5% | +7.3% | +3.9% | +43.5% | +26.6% | +16.9% | +4.2% |
| YoY Change | — | — | — | — | +32.8% | +39.0% | +31.8% | +47.9% | +43.2% | +34.8% | +32.3% | +32.1% | +34.1% | +34.2% | +30.2% | +28.3% | +63.9% | +102.6% | +120.6% | +121.1% |
Range$160.81M – $1.04B
CAGR+48.0%
Avg YoY Growth+51.8%
Median YoY Growth+34.5%
Current Streak16 quarters growth
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's net product revenues — total revenues?
- Alnylam Pharmaceuticals (ALNY) reported net product revenues — total revenues of $1.04B in Q1 2026.
- How has Alnylam Pharmaceuticals's net product revenues — total revenues changed year-over-year?
- Alnylam Pharmaceuticals's net product revenues — total revenues increased by 121.1% year-over-year, from $468.54M to $1.04B.
- What is the long-term trend for Alnylam Pharmaceuticals's net product revenues — total revenues?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's net product revenues — total revenues has grown at a 45.7% compound annual growth rate (CAGR), from $662.14M to $2.99B.